Indians to benefit from Canada's family reunification programme
Darpan News Desk IANS, 21 Jul, 2021 04:31 PM
A record number of 40,000 immigrant families will be allowed to sponsor their parents and grandparents to bring them to Canada in 2021.
This means 30,000 additional applications will be accepted as against the annual intake of 10,000 under the Parents and Grandparents Programme (PGP), which is aimed at family reunification.
Since Indo-Canadians are one of the fastest growing communities in Canada, they will be the major beneficiaries of the programme.
Applications can be submitted online over a two-week period, starting September 20.
Using the random selection process, those whose applications are accepted would be allowed to bring their parents and grandparents to Canada.
Since the sponsors have to show a certain minimum income requirement, the Canadian government has allowed them to include state benefits received during the Covid lockdown towards their income. This will ensure that applicants are not penalised for lost income during the pandemic.
Unveiling the programme, Canadian Immigration Minister Marco E.L. Mendicino said, "The importance of family has never been clearer than during the pandemic. That is why we are delivering on our commitment to help more families reunite in Canada.
"By strengthening the Parents and Grandparents Programme, inviting a record number of sponsors to apply, and by adjusting our requirements to adapt to the current times, we are once again proving our commitment to helping Canadian families stay together, and thrive together."
The committee makes no similar call for opposition parties to promise not to trigger an election during the pandemic by voting non-confidence in the government.
Chief Justice Christopher Hinkson said during a hearing on Tuesday people are still free to hold and express religious views and it's the safety of those who are gathering that's at issue.
On the one hand, Health Canada says Oxford-AstraZeneca’s vaccine has been deemed safe for seniors and points to emerging real-world data that shows it can protect older citizens against symptomatic infection.
The machines, called MySafe, are similar to ATMs and allow drug users at risk of overdose to get hydromorphone pills dispensed to them after their palm has been scanned.
Alberto Martin, a University of Toronto immunology professor, says a published clinical trial showed the first dose of the Pfizer-BioNTech vaccine provided 60 per cent protection, but B.C. may have access to new or unpublished data.
